Metabolic Score for Insulin Resistance (METS-IR)
ورودیهای بالینی بیمار
حداقل ۴۰ — حداکثر ۷۰۰ • واحد: mg/dL
حداقل ۱۰ — حداکثر ۲۰۰۰ • واحد: mg/dL
حداقل ۱۰ — حداکثر ۷۰ • واحد: kg/m²
حداقل ۱۰ — حداکثر ۲۰۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–50.39
- High Risk50.39–999
The Metabolic Score for Insulin Resistance (METS-IR) calculator is designed for bedside predicting risk of type 2 diabetes in previously undiagnosed patients using fasting glucose, triglycerides, BMI, and HDL cholesterol in clinical practice. The resulting score directly guides clinician decision-making regarding titrating insulin infusion protocols.
Clinical Guidelines & Evidence
Predicts risk of type 2 diabetes in previously undiagnosed patients using fasting glucose, triglycerides, BMI, and HDL cholesterol. A simple, non-insulin dependent marker for insulin resistance.
Clinical Indication
The Metabolic Score for Insulin Resistance (METS-IR) is indicated for bedside clinical practice to support Predicts risk of type 2 diabetes in previously undiagnosed patients using fasting glucose, triglycerides, BMI, and HDL cholesterol. A simple, non-insulin dependent marker for insulin resistance.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: May need further validation in other ethnic populations.
METS-IR = (ln((2 × Fasting Glucose) + Triglycerides) × BMI) / ln(HDL Cholesterol)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| fasting_glucose | float | Yes | Fasting plasma glucose level(mg/dL) |
| triglycerides | float | Yes | Fasting triglyceride level(mg/dL) |
| bmi | float | Yes | Body Mass Index calculated as weight(kg)/height(m)²(kg/m²) |
| hdl_cholesterol | float | Yes | High-density lipoprotein cholesterol level(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–50.39 | Low Risk | METS-IR ≤50.39 |
| 50.39–999 | High Risk | METS-IR >50.39 |
Evidence-Based References (EBM)
- Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018 May;178(5):533-544.
- Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, et al. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020 May;39(5):1613-1621.
- Zhang M, Liu D, Qin P, et al. Association of metabolic score for insulin resistance and its 6-year change with incident type 2 diabetes mellitus. J Diabetes. 2021 Sep;13(9):725-734.